Skip to main content

Louise manages a portfolio of technologies from Weill Cornell Medicine. Prior to joining CTL Louise was based in Singapore where she was Head of Business Development and Licensing for D3, a drug development group based at A*STAR, Singapore’s lead research agency. Some of her previous roles include Corporate Development Manager at S*BIO Pte Ltd. (Singapore), an oncology focused biotech and Vice President of Business Development at Paramount Biosciences (London), where she was responsible for in-licensing drug development assets. Louise has also worked for leading life science and healthcare communication agencies and UCL Business, the commercialization company of University College London.

Education

  • PhD – Biochemical Engineering, University College London (London, UK)
  • MSc – Biotechnology, Nottingham Trent University (Nottingham, UK)
  • B.Eng (Hons) – Chemical & Process Engineering, Newcastle University (Newcastle-upon-Tyne, UK)